Workflow optimization of whole genome amplification and targeted panel sequencing for CTC mutation detection

[1]  M. Cristofanilli,et al.  Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients , 2017, Breast Cancer Research and Treatment.

[2]  Srikanth S. Manda,et al.  Data-Driven Discovery of Extravasation Pathway in Circulating Tumor Cells , 2017, Scientific Reports.

[3]  T. Maudelonde,et al.  Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair. , 2017, Clinical chemistry.

[4]  S. Jeffrey,et al.  Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer , 2016, Oncotarget.

[5]  C. Camps,et al.  Circulating tumor cells versus circulating tumor DNA in lung cancer-which one will win? , 2016, Translational lung cancer research.

[6]  P. Robson,et al.  Tumor-derived circulating endothelial cell clusters in colorectal cancer , 2016, Science Translational Medicine.

[7]  Simak Ali,et al.  Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell Counts , 2016, Clinical Cancer Research.

[8]  A. Vannucchi,et al.  Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer , 2016, Oncotarget.

[9]  C. Dive,et al.  Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  W. Choi,et al.  Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer , 2016, Oncotarget.

[11]  M R Speicher,et al.  The biology of circulating tumor cells , 2016, Oncogene.

[12]  Di Shao,et al.  A targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinoma , 2016, Scientific Reports.

[13]  Chwee Teck Lim,et al.  Microfluidic enrichment for the single cell analysis of circulating tumor cells , 2016, Scientific Reports.

[14]  L. Chodosh,et al.  A novel approach for next‐generation sequencing of circulating tumor cells , 2016, Molecular genetics & genomic medicine.

[15]  Rajan P Kulkarni,et al.  Classification of large circulating tumor cells isolated with ultra-high throughput microfluidic Vortex technology , 2016, Oncotarget.

[16]  Crispin J. Miller,et al.  Genetic profiling of tumours using both circulating free DNA and circulating tumour cells isolated from the same preserved whole blood sample , 2015, Molecular oncology.

[17]  S. Fujita,et al.  Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations , 2015, BMC Cancer.

[18]  R. Datar,et al.  Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer. , 2015, Cancer research.

[19]  S. Jeffrey,et al.  Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility , 2015, Clinical Cancer Research.

[20]  P. Jänne,et al.  Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses , 2015, Clinical Cancer Research.

[21]  Ting Wang,et al.  Comparison of variations detection between whole-genome amplification methods used in single-cell resequencing , 2015, GigaScience.

[22]  N. Yang,et al.  Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers , 2015, PloS one.

[23]  Udo Schumacher,et al.  Establishment and characterization of a cell line from human circulating colon cancer cells. , 2015, Cancer research.

[24]  Siddharth S. Dey,et al.  Integrated genome and transcriptome sequencing from the same cell , 2014, Nature Biotechnology.

[25]  P. Paterlini-Bréchot,et al.  Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion , 2014, OncoTargets and therapy.

[26]  E. Rappaport,et al.  Dielectrophoretic Capture and Genetic Analysis of Single Neuroblastoma Tumor Cells , 2014, Front. Oncol..

[27]  K Dane Wittrup,et al.  Tumor cells are dislodged into the pulmonary vein during lobectomy. , 2014, The Journal of thoracic and cardiovascular surgery.

[28]  Leslie Cope,et al.  Clinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing. , 2014, American journal of clinical pathology.

[29]  V. Velculescu,et al.  Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA. , 2014, Cancer discovery.

[30]  Rajan P Kulkarni,et al.  Size-selective collection of circulating tumor cells using Vortex technology. , 2014, Lab on a chip.

[31]  P. Nürnberg,et al.  Enrichment of target sequences for next-generation sequencing applications in research and diagnostics , 2013, Biological chemistry.

[32]  S. Jeffrey,et al.  Circulating tumor cells versus tumor-derived cell-free DNA: rivals or partners in cancer care in the era of single-cell analysis? , 2013, Genome Medicine.

[33]  I. Tinhofer,et al.  Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition , 2012, BMC Cancer.

[34]  D. Pinkel,et al.  Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer , 2012, BMC Cancer.

[35]  K. Pantel,et al.  Circulating tumor cells and circulating tumor DNA. , 2012, Annual review of medicine.

[36]  Richard W Tothill,et al.  Next-generation sequencing for cancer diagnostics: a practical perspective. , 2011, The Clinical biochemist. Reviews.

[37]  Caroline Dive,et al.  Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[39]  P. Jänne,et al.  A new device for rapid isolation by size and characterization of rare circulating tumor cells. , 2011, Anticancer research.

[40]  Lei Li,et al.  Whole genome amplification in preimplantation genetic diagnosis , 2011, Journal of Zhejiang University SCIENCE B.

[41]  G. Doyle,et al.  Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer , 2009, Journal of oncology.

[42]  K. Kinzler,et al.  Serial assessment of human tumor burdens in mice by the analysis of circulating DNA. , 2007, Cancer research.

[43]  Leon W.M.M. Terstappen,et al.  Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer , 2006, Clinical Cancer Research.

[44]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[45]  Vladimir Makarov,et al.  Two methods of whole-genome amplification enable accurate genotyping across a 2320-SNP linkage panel. , 2004, Genome research.

[46]  S. Jewell,et al.  Copyright © American Society for Investigative Pathology Review Effect of Fixatives and Tissue Processing on the Content and Integrity of Nucleic Acids , 2022 .

[47]  Aditi Das,et al.  Clinical case study. , 2013, Community eye health.